overdose of tirzepatide GLP-1 overdoses have been skyrocketing, with poison centers seeing a nearly 1500% increase in calls related to or side effects injectable weight-loss drugs since 2019, according to US National Poison Mounjaro (Tirzepatide) Weight Loss Injections

10.1001/jama.2021.1831 31

Packaging materials is in line with the requirements of FDA

Vietnam J

Zizzari P, He R, Falk S, Bellocchio L, Allard C, Clark S, et al

(2014) MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivo , Oncogenesis , 3 , 99, doi: Liu, Z., Wang, J., Li, Y., Fan, J., Chen, L., and Xu, R

Limitations of Use: Compounded semaglutide should not be used in combination with other semaglutide-containing products or any other GLP-1/GIP receptor agonist medicines.The safety and efficacy of coadministration with other products for weight loss have not been established.Compounded semaglutide has not been studied in patients with a history of pancreatitis.Note: Compounded medications are not FDA approved and do not have indications for treatment as an FDA approved medication would